These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8126765

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man.
    Hayes JP, Ridge SM, Griffith S, Barnes PJ, Chung KF.
    J Allergy Clin Immunol; 1991 Jul; 88(1):83-8. PubMed ID: 2071787
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ, O'Neill C.
    Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.
    da Silva MB, Herion F, Raskinet R, David JL, Gustin P, Dessy C, Lekeux P.
    Zentralbl Veterinarmed A; 1996 Sep; 43(7):399-413. PubMed ID: 8921726
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
    Evans TW, Dent G, Rogers DF, Aursudkij B, Chung KF, Barnes PJ.
    Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves.
    Bastos da Silva MB, Gustin P, Herion F, Raskinet R, David JL, Gougnard T, Plomteux G, Desmecht D, Lekeux P.
    Vet Res Commun; 1997 Oct; 21(7):521-31. PubMed ID: 9345719
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
    Korth R, Hirafuji M, Keraly CL, Delautier D, Bidault J, Benveniste J.
    Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
    [Abstract] [Full Text] [Related]

  • 18. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity.
    Parry MJ, Alabaster VA, Cheeseman HE, Cooper K, deSouza RN, Keir RF.
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):251-68. PubMed ID: 7812676
    [Abstract] [Full Text] [Related]

  • 20. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM, Bernat A, Valette G, Gigo V, Lale A, LaPlace MC, Lespy L, Savi P, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.